Clinical Trial Update: Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Pioglitazone for patients with Type 2 Diabetes Mellitus and Coronary Heart Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: IKFE Institute for Clinical Research and Development | Conditions: Type 2 Diabetes Mellitus, Cardiovascular Disease | Phase 4 | Status: COMPLETED